Researchers develop new approach to effectively deliver therapeutics into the brain

Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach-;demonstrated in mouse models and isolated human brain tissue-;to safely and effectively deliver therapeutics into the brain, providing new possibilities for treating a wide range of neurological and psychiatric diseases.

CPT Code for Prior Authorization May Still Happen — Eventually

Remember that physician who wanted to develop a Current Procedural Terminology (CPT) code for prior authorizations? It hasn’t happened yet, but he hasn’t given up

July 9, 2024

In a world first, Vertex, CRISPR win UK approval for CRISPR-edited therapy to treat sickle cell disease, beta-thalassemia

Vertex and CRISPR Therapeutics have won the first-ever approval for a therapy created with CRISPR gene editing, as the UK drug regulator MHRA greenlights their

November 17, 2023

Text message reminders fail to boost long-term medication adherence

A new study published today in JAMA reveals text message reminders for patients who delay refilling their medications didn’t help improve how regularly they refilled

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.